These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4935362)

  • 21. Post-transplant glomerulonephritis under conventional and cyclosporin A immunosuppression.
    Yussim A; Ben-Bassat M; Shapira Z; Shmueli D; Shaharabani E; Lustig S; Nakache R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2119-20. PubMed ID: 2652684
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of immunosuppressive, anticoagulant and anti-inflammatory agents on experimental glomerulonephritis. VI. Encorton, immuran and cyclophosphamide].
    Tyszkiewicz Z; Gawlik Z; Lewandowska T; Juska D
    Patol Pol; 1984; 35(1):105-14. PubMed ID: 6493817
    [No Abstract]   [Full Text] [Related]  

  • 23. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
    Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of primary proliferative glomerulonephritis by azathioprine].
    Fries D; Bruna-Blanc N; Banssillon V; Zech P; Touboul P; Canarelli G; Traeger J
    J Urol Nephrol (Paris); 1968 Dec; 74(12):1012-21. PubMed ID: 4886358
    [No Abstract]   [Full Text] [Related]  

  • 25. [Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis].
    Klinger M; Szewczyk Z
    Przegl Lek; 1989; 46(10):744-9. PubMed ID: 2687950
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of primary chronic glomerulonephritis with a triple combination of prednisone, azathioprine and a nitrogen mustard derivative].
    Traver JA; Guajardo DS; Botella J
    Rev Clin Esp; 1975 May; 137(4):321-5. PubMed ID: 1144863
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful immunosuppressive treatment of oliguric extracapillary glomerulonephritis.
    Jensen H; Olgaard K; Faarup P
    Acta Med Scand; 1974 Nov; 196(5):383-6. PubMed ID: 4440516
    [No Abstract]   [Full Text] [Related]  

  • 29. Regression of dense deposits in Type II membranoproliferative glomerulonephritis: case report of clinical course in a child.
    Kher KK; Makker SP; Aikawa M; Kirson IJ
    Clin Nephrol; 1982 Feb; 17(2):100-3. PubMed ID: 7067166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 31. Deterioration of renal function after discontinuation of long-term prednisone-azathioprine therapy in primary renal disease.
    Levitt JI
    N Engl J Med; 1970 May; 282(20):1125-7. PubMed ID: 5439410
    [No Abstract]   [Full Text] [Related]  

  • 32. Progression from minimal or focal to diffuse proliferative lupus nephritis.
    Zimmerman SW; Jenkins PG; Shelf WD; Bloodworth JM; Burkholder PM
    Lab Invest; 1975 May; 32(5):665-72. PubMed ID: 1092911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytostatic treatment of glomerular diseases. IV. The effect of combined immunosuppressive treatment on serum creatinine and proteinuria evaluated by sequential statistical analysis. Report from a Copenhagen study group of renal diseases.
    Balsløv JT; Brun C; Jørgensen F; Jørgensen HE; Larsen M; Larsen S; Lorenzen I; Thomsen AC
    Acta Med Scand; 1978; 203(5):339-44. PubMed ID: 352097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of azathioprine on renal histology and function in lupus nephritis.
    Shelp WD; Bloodworth JM; Rieselbach RE
    Arch Intern Med; 1971 Oct; 128(4):566-73. PubMed ID: 5111661
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long term treatment of chronic glomerulonephritis, clinical course and results of renal biopsies].
    Brass H; Lapp H; Heintz R
    Arch Klin Med; 1969; 216(4):303-23. PubMed ID: 4983036
    [No Abstract]   [Full Text] [Related]  

  • 36. [Indications and limitations of immunodepressive therapy in glomerular nephropathies. Initial morphologic and functional findings and changes in the level of some plasma proteins].
    Scarpioni L; Maiorca R; Cambi V; Carrara GC; Dall'Aglio P
    Minerva Nefrol; 1969; 16(2):157-62. PubMed ID: 5398501
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of the treatment of mesangiocapillary glomerulonephritis].
    Rodríguez JA; Olmos A; Ferrer E; Mauri JM; Capdevilla L; Codina S; Alsina J; Camps J; Piera L
    Rev Clin Esp; 1975 Dec; 139(5):415-22. PubMed ID: 1215585
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of developing glomerulonephritis using immunosuppressive drugs].
    Botella García J; Ortuño Mirete J
    Rev Clin Esp; 1968 Oct; 111(1):59-62. PubMed ID: 5746794
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic possibilities in chronic glomerulonephritis].
    Brass H
    Munch Med Wochenschr; 1969 Aug; 111(35):1759-66. PubMed ID: 5820240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.